{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:56:10Z","timestamp":1795110970189,"version":"4.10.3"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T00:00:00Z","timestamp":1609286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.waojou.2020.100505","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T01:37:05Z","timestamp":1612661825000},"page":"100505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["The other side of the coin: IgE deficiency, a susceptibility factor for malignancy occurrence"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9799-4800","authenticated-orcid":false,"given":"Denisa","family":"Ferastraoaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5884-8256","authenticated-orcid":false,"given":"Galateja","family":"Jordakieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4019-5765","authenticated-orcid":false,"given":"Erika","family":"Jensen-Jarolim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.waojou.2020.100505_bib1","first-page":"151","article-title":"Immunoglobulin E, a new class of human immunoglobulin","volume":"38","year":"1968","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.waojou.2020.100505_bib2","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jaci.2015.12.1343","article-title":"Identification of IgE","volume":"137","author":"Ishizaka","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2020.100505_bib3","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.jaci.2016.04.004","article-title":"The discovery of IgE","volume":"137","author":"Johansson","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100505_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fimmu.2014.00061","article-title":"Helminth allergens, parasite-specific IgE, and its protective role in human immunity","volume":"5","author":"Fitzsimmons","year":"2014","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2020.100505_bib5","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.jaci.2016.04.010","article-title":"IgE in the diagnosis and treatment of allergic disease","volume":"137","author":"Platts-Mills","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100505_bib6","first-page":"53","article-title":"Hyperimmunoglobulin E syndrome: genetics, immunopathogenesis, clinical findings, and treatment modalities","volume":"22","author":"Hashemi","year":"2017","journal-title":"J\u00a0Res Med Sci : the official journal of Isfahan University of Medical Sciences"},{"issue":"3","key":"10.1016\/j.waojou.2020.100505_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12016-016-8559-2","article-title":"Atopy and specific cancer sites: a review of epidemiological studies","volume":"51","author":"Cui","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2020.100505_bib8","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1154250","article-title":"Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival","volume":"5","author":"Wulaningsih","year":"2016","journal-title":"OncoImmunology"},{"issue":"8","key":"10.1016\/j.waojou.2020.100505_bib9","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/annonc\/mdv231","article-title":"IgE and risk of cancer in 37 747 individuals from the general population","volume":"26","author":"Helby","year":"2015","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.waojou.2020.100505_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137503","article-title":"Association between prediagnostic allergy-related serum cytokines and glioma","volume":"10","author":"Schwartzbaum","year":"2015","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.waojou.2020.100505_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000447692","article-title":"A\u00a0critical evaluation of anti-IL-13 and anti-IL-4 strategies in severe asthma","volume":"170","author":"Bagnasco","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"issue":"16","key":"10.1016\/j.waojou.2020.100505_bib12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/jnci\/djs315","article-title":"Association between prediagnostic IgE levels and risk of glioma","volume":"104","author":"Schwartzbaum","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.waojou.2020.100505_bib13","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1398-9995.2011.02670.x","article-title":"Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort","volume":"66","author":"Schlehofer","year":"2011","journal-title":"Allergy"},{"issue":"18 Pt 1","key":"10.1016\/j.waojou.2020.100505_bib14","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1158\/1078-0432.CCR-06-2819","article-title":"Polyclonal immunoglobulin E levels are correlated with hemoglobin values and overall survival in patients with multiple myeloma","volume":"13","author":"Matta","year":"2007","journal-title":"Clin Canc Res"},{"issue":"8","key":"10.1016\/j.waojou.2020.100505_bib15","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1158\/0008-5472.CAN-05-4032","article-title":"Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival","volume":"66","author":"Wrensch","year":"2006","journal-title":"Canc Res"},{"issue":"10","key":"10.1016\/j.waojou.2020.100505_bib16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1398-9995.2008.01768.x","article-title":"AllergoOncology: the role of IgE-mediated allergy in cancer","volume":"63","author":"Jensen-Jarolim","year":"2008","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.waojou.2020.100505_bib17","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1089\/hum.2006.17.1134","article-title":"Adoptive transfer of chimeric FcepsilonRI gene-modified human T cells for cancer immunotherapy","volume":"17","author":"Teng","year":"2006","journal-title":"Hum Gene Ther"},{"issue":"5","key":"10.1016\/j.waojou.2020.100505_bib18","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.4049\/jimmunol.179.5.2832","article-title":"IgE-antibody-dependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cells","volume":"179","author":"Karagiannis","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2020.100505_bib19","first-page":"915","article-title":"Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2\/neu-positive tumour cells. Cancer immunology, immunotherapy","volume":"58","author":"Karagiannis","year":"2009","journal-title":"CII"},{"issue":"9","key":"10.1016\/j.waojou.2020.100505_bib20","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.celrep.2015.02.015","article-title":"IgE\/Fc\u03b5RI-mediated antigen cross-presentation by dendritic cells enhances anti-tumor immune responses","volume":"10","author":"Platzer","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.waojou.2020.100505_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ebiom.2019.03.080","article-title":"IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states","volume":"43","author":"Pellizzari","year":"2019","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.waojou.2020.100505_bib22","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/all.13119","article-title":"AllergoOncology - the impact of allergy in oncology: EAACI position paper","volume":"72","author":"Jensen-Jarolim","year":"2017","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.waojou.2020.100505_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/all.13311","article-title":"AllergoOncology: opposite outcomes of immune tolerance in allergy and cancer","volume":"73","author":"Jensen-Jarolim","year":"2018","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.waojou.2020.100505_bib24","doi-asserted-by":"crossref","first-page":"100044","DOI":"10.1016\/j.waojou.2019.100044","article-title":"AllergoOncology: high innate IgE levels are decisive for the survival of cancer-bearing mice","volume":"12","author":"Singer","year":"2019","journal-title":"The World Allergy Organization journal"},{"issue":"7","key":"10.1016\/j.waojou.2020.100505_bib25","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.4049\/jimmunol.1601026","article-title":"Cutting edge: IgE plays an active role in tumor immunosurveillance in mice","volume":"197","author":"Nigro","year":"2016","journal-title":"J\u00a0Immunol"},{"issue":"8","key":"10.1016\/j.waojou.2020.100505_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/s41590-018-0161-8","article-title":"Epithelial damage and tissue \u03b3\u03b4 T cells promote a unique tumor-protective IgE response","volume":"19","author":"Crawford","year":"2018","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2020.100505_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0091-6749(80)90026-3","article-title":"Age-related serum immunoglobulin E levels in healthy subjects and in patients with allergic disease","volume":"66","author":"Wittig","year":"1980","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2020.100505_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1081-1206(10)63188-2","article-title":"Clinical manifestations of IgE hypogammaglobulinemia","volume":"78","author":"Smith","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2020.100505_bib29","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.2500\/aap.2014.35.3734","article-title":"Selective IgE deficiency, immune dysregulation, and autoimmunity","volume":"35","author":"Magen","year":"2014","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.waojou.2020.100505_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13601-020-00335-w","article-title":"AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a position paper of the European Academy of allergy and clinical immunology (EAACI)","volume":"10","author":"Ferastraoaru","year":"2020","journal-title":"Clin Transl Allergy"},{"issue":"9","key":"10.1016\/j.waojou.2020.100505_bib31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM196908282810904","article-title":"Immunoglobulin E deficiency in ataxia-telangiectasia","volume":"281","author":"Ammann","year":"1969","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.waojou.2020.100505_bib32","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1378\/chest.96.3.516","article-title":"Familial IgE deficiency associated with sinopulmonary disease","volume":"96","author":"Schoettler","year":"1989","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.waojou.2020.100505_bib33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM197009032831018","article-title":"Healthy IgE-deficient person","volume":"283","author":"Levy","year":"1970","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.waojou.2020.100505_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.anai.2017.07.006","article-title":"Increased malignancy incidence in IgE deficient patients not due to concomitant Common Variable Immunodeficiency","volume":"119","author":"Ferastraoaru","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100505_bib35","article-title":"Increased malignancy rate in children with IgE deficiency: a single-center experience","author":"Ferastraoaru","year":"2020","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"5","key":"10.1016\/j.waojou.2020.100505_bib36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.anai.2018.07.036","article-title":"IgE deficiency and prior diagnosis of malignancy: results of the 2005-2006 national Health and nutrition examination Survey","volume":"121","author":"Ferastraoaru","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2020.100505_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jaip.2019.06.031","article-title":"IgE deficiency is associated with high rates of new malignancies: results of a longitudinal cohort study","volume":"8","author":"Ferastraoaru","year":"2020","journal-title":"The journal of allergy and clinical immunology In practice"},{"issue":"3","key":"10.1016\/j.waojou.2020.100505_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10875-018-0476-0","article-title":"Low serum IgE is a sensitive and specific marker for common variable immunodeficiency (CVID)","volume":"38","author":"Lawrence","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2020.100505_bib39","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1398-9995.2005.00799.x","article-title":"The association of selective IgA deficiency and IgE hypogammaglobulinemia","volume":"60","author":"Levy","year":"2005","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2020.100505_bib40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/cei.12885","article-title":"Low immunoglobulin E flags two distinct types of immune dysregulation","volume":"187","author":"Elkuch","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.waojou.2020.100505_bib41","doi-asserted-by":"crossref","first-page":"146715","DOI":"10.1155\/2008\/146715","article-title":"Molecular analysis of activation-induced cytidine deaminase gene in immunoglobulin-E deficient patients","volume":"2008","author":"Roa","year":"2008","journal-title":"Clin Dev Immunol"},{"issue":"9","key":"10.1016\/j.waojou.2020.100505_bib42","first-page":"1591","article-title":"Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer. Cancer immunology, immunotherapy","volume":"61","author":"Mechtcheriakova","year":"2012","journal-title":"CII"},{"issue":"1","key":"10.1016\/j.waojou.2020.100505_bib43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/s12864-016-3001-y","article-title":"AID\/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer","volume":"17","author":"Svoboda","year":"2016","journal-title":"BMC Genom"},{"issue":"8","key":"10.1016\/j.waojou.2020.100505_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012204","article-title":"Relationships between levels of serum IgE, cell-bound IgE, and IgE-receptors on peripheral blood cells in a pediatric population","volume":"5","author":"Dehlink","year":"2010","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.waojou.2020.100505_bib45","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1084\/jem.185.4.663","article-title":"IgE enhances mouse mast cell Fc(epsilon)RI expression in\u00a0vitro and in\u00a0vivo: evidence for a novel amplification mechanism in IgE-dependent reactions","volume":"185","author":"Yamaguchi","year":"1997","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.waojou.2020.100505_bib46","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S1081-1206(10)61095-2","article-title":"Relationship between extremely low total serum IgE levels and rhinosinusitis","volume":"97","author":"Levin","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100505_bib47","article-title":"Higher rates of malignancy in IgE deficient patients with negative immediate hypersensitivity skin tests","author":"Ferastraoaru","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2020.100505_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000236714","article-title":"Distribution of immunoglobulins in squamous cell carcinoma of the head and neck","volume":"104","author":"Neuchrist","year":"1994","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.waojou.2020.100505_bib49","series-title":"2020;AACR Annual Meeting","article-title":"Phase 1 trial of MOv18, a first-in-class IgE antibody therapy for cancer","author":"Spicer","year":"2020"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120304087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120304087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:43:35Z","timestamp":1761849815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455120304087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1939455120304087"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100505","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The other side of the coin: IgE deficiency, a susceptibility factor for malignancy occurrence","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100505"}}